Compare · CNCR vs DWAW

CNCR vs DWAW

Side-by-side comparison of Loncar Cancer Immunotherapy ETF (CNCR) and AdvisorShares Dorsey Wright FSM All Cap World ETF (DWAW): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both CNCR and DWAW operate in n/a (n/a), so they compete in similar markets.
MetricCNCRDWAW
Company
Loncar Cancer Immunotherapy ETF
AdvisorShares Dorsey Wright FSM All Cap World ETF
Price
-
-
Market cap
-
-
1M return
-
-
1Y return
-
-
Sector
n/a
n/a
Industry
n/a
n/a
Exchange
NASDAQ
NASDAQ
IPO
n/a
n/a
News (4w)
0
0
Recent ratings
0
0
CNCR

Loncar Cancer Immunotherapy ETF

The investment seeks to track the total return performance, before fees and expenses, of the Loncar Cancer Immunotherapy Index. The index is composed of the common stock of approximately 30 pharmaceutical or biotechnology companies identified by the fund's index provider, as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. The adviser attempts to invest all, or substantially all, of its assets in the component securities and ADRs that make up the index. Normally it will invest at least 80% of its total assets in the component securities of the index. The fund is non-diversified.

DWAW

AdvisorShares Dorsey Wright FSM All Cap World ETF

The investment seeks to provide long-term capital appreciation with capital preservation as a secondary objective. The fund is an actively managed exchange-traded fund ("ETF") that is primarily a "fund of funds." The Advisor seeks to achieve it's investment objective by investing in ETFs that invest primarily in domestic and foreign equity securities of any capitalization, including in emerging markets. The fund invests in fixed income ETFs with a short or ultra-short duration, money market funds, cash and cash equivalents ("Defensive Investments"). It may invest in affiliated and unaffiliated ETFs.

Latest CNCR

No recent items for Loncar Cancer Immunotherapy ETF.

Latest DWAW